FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj
The FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.